Facebook Linkedin Twitter
Inside Precision Medicine NSCLC Outcomes Significantly Improved with Immunotherapy Treatments Given Before and After Surgery

Phase III clinical trials (Clinical trial)

Lung cancer, close-up, NSCLC
News & Features

NSCLC Outcomes Significantly Improved with Immunotherapy Treatments Given Before and After Surgery

0
Vials on plate
News & Features

Harmony Acquiring Zynerba, a Leader in Development of Cannabioid-Based Gel

0
Woman cancer patient
News & Features

Are We Nearly There Yet?

Laura Cowen
0
antibodies
News & Features

Charging to the Frontline

Chris Anderson
0
Lung cancer, conceptual image
News & Features

Lilly’s Retevmo Beats PD-1 Combo for RET Fusion-Positive Lung Cancer

0
Cancer Cell
News & Features

New Regimen Improves Graft-Versus-Host Disease Response

0
Illustration of the prostate organ in blue surrounded by red cancer cells to symbolize prostate cancer
News & Features

Bone Biomarkers Linked to Prostate Cancer Survival

0
Brain MRI Scan of Healthy Male ( Magnetic Resonance Imaging) High Resolution Medical Images
News & Features

Lilly’s Donanemab Shines in Phase III for Alzheimer’s

2
X-ray style image of the top part of a woman's body showing the lungs highlighted and four red lung cancer tumors of different sizes
News & Features

Pragmatica-Lung Study Aims to Streamline Cancer Trials

0
Hospitalized cancer patient undergoing chemotherapy.
News & Features

Lung Cancer Outcomes Improve when Immunotherapy is Given Before and After Surgery

0
12345Page 3 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine